Differences in Metabolites of Different Tongue Coatings in Patients with Chronic Hepatitis B

Table 2

Clinical and biological characteristics of 100 patients with chronic hepatitis B and 25 normal subjects.

	Group A	Group B	Group C
	(𝑛=50)	(𝑛=50)	(𝑛=25)
Age (years)	36 (22, 58)	37.5 (17, 50)	35 (20, 57)
Gender (M/F)	50 (43/7)*	50 (44/6)*	25 (15/10)
Course of disease (years)	4 (0.6, 23)	7.5 (0.6, 27)	—
TBIL (μmol/L)	14.21 (5.2, 81.21)	18.19 (8.65, 245.41)	14.9 (6.9, 20.5)
DBIL (μmol/L)	5.75 (2.5, 62.9)*	6.35 (2.5, 201.4)*	4.2 (3, 5.3)
IDBIL (μmol/L)	10.15 (1.3, 28.7)	11.75 (4.5, 44)	10.7 (3.9, 15.9)
ALT (IU/L)	66 (23, 365)*	67.5 (22, 584)*	17 (10, 31)
AST (IU/L)	39.5 (25, 131)*	37.5 (20, 286)*	19 (14, 35)
GGT (IU/L)	39.5 (7, 436)*	45 (5, 634)*	19 (10, 63)
ALP (IU/L)	84 (47, 211)*	96 (39, 182)*	53 (13, 96)
TP (g/L)	73.5 (53, 86)	74 (61, 84)	72 (62, 79)
ALB (g/L)	30 (9, 48)*	28 (19, 49)*	44 (38, 63)
TBA (μmol/L)	16 (2, 311)*	17.5 (2, 390)*	8 (5, 12)
HBsAg (IU/mL)	250 (15.25, 250)*	250 (0.27, 250)*	0.01 (0, 0.02)
HBeAg (S/CO)	37 (13)	30 (20)	—
log DNA (copies/mL)	5.03 (3.05, 9.24)	5.01 (3.13, 8.04)	—

Statistical analysis of data among groups was performed by the Kruskal-Wallis test, and significant differences were compared with Group C (*𝑃<0.05).